32 related articles for article (PubMed ID: 5329155)
21. Metabolism of hydrazine anti-cancer agents.
Tweedie DJ; Erikson JM; Prough RA
Pharmacol Ther; 1987; 34(1):111-27. PubMed ID: 3310042
[No Abstract] [Full Text] [Related]
22. Use of a methyl hydrazine derivative (natulan), especially in Hodgkin's disease.
Hansen MM; Hertz H; Videaek A
Acta Med Scand; 1966 Aug; 180(2):211-24. PubMed ID: 5329155
[No Abstract] [Full Text] [Related]
23. Antineoplastic and immunosuppressive drugs. II. Therapeutic uses.
Cridland MD
Drugs; 1972; 3(5):331-51. PubMed ID: 4347084
[No Abstract] [Full Text] [Related]
24. [Natulan (experimental and clinical data on its antitumor effect)].
Brodskaia NA
Vopr Onkol; 1972; 18(11):101-9. PubMed ID: 4566561
[No Abstract] [Full Text] [Related]
25. Chemotherapy of the non-Hodgkin's lymphomas.
Canellos GP; Lister TA; Skarin AT
Cancer; 1978 Aug; 42(2 Suppl):932-40. PubMed ID: 356958
[No Abstract] [Full Text] [Related]
26. The comparative value of several tests in predicting the response to chemotherapy in patients with malignant hemophathies.
Cheţa D; Micu D; Cheţa N
Med Interne; 1979; 17(4):353-7. PubMed ID: 390678
[No Abstract] [Full Text] [Related]
27. Leukaemia and cancer in relation to immunosuppressive therapy.
Videbaek A
Scand J Haematol; 1973; 10(4):241-3. PubMed ID: 4587559
[No Abstract] [Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
